Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Touro College and University System

2018

Risk Factors

Articles 1 - 3 of 3

Full-Text Articles in Medicine and Health Sciences

Global, Regional, And National Disability-Adjusted Life-Years (Dalys) For 359 Diseases And Injuries And Healthy Life Expectancy (Hale) For 195 Countries And Territories, 1990–2017: A Systematic Analysis For The Global Burden Of Disease Study 2017, Hmwe Hmwe Kyu, Degu Abate, Kalkidan Hassen Abate, Solomon M. Abay, Cristiana Abbafati, Mohammad Tavakkoli, Nooshin Abbasi, Hedayat Abbastabar, Foad Abd-Allah, Jemal Abdela, Ahmed Abdelalim, Ibrahim Abdollahpour, Rizwan Suliankatchi Abdulkader, Gbd 2017 Dalys And Hale Collaborators Nov 2018

Global, Regional, And National Disability-Adjusted Life-Years (Dalys) For 359 Diseases And Injuries And Healthy Life Expectancy (Hale) For 195 Countries And Territories, 1990–2017: A Systematic Analysis For The Global Burden Of Disease Study 2017, Hmwe Hmwe Kyu, Degu Abate, Kalkidan Hassen Abate, Solomon M. Abay, Cristiana Abbafati, Mohammad Tavakkoli, Nooshin Abbasi, Hedayat Abbastabar, Foad Abd-Allah, Jemal Abdela, Ahmed Abdelalim, Ibrahim Abdollahpour, Rizwan Suliankatchi Abdulkader, Gbd 2017 Dalys And Hale Collaborators

NYMC Faculty Publications

BACKGROUND: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure of disability-adjusted life-years (DALYs), a composite measure of disease burden capturing both premature mortality and prevalence and severity of ill health, for 359 diseases and injuries for …


Systematic Overview Of Hepatitis C Infection In The Middle East And North Africa, Karima Chaabna, Sohaila Cheema, Amit Abraham, Hekmat Alrouh, Albert B. Lowenfels, Patrick Maisonneuve, Ravinder Mamtani Jul 2018

Systematic Overview Of Hepatitis C Infection In The Middle East And North Africa, Karima Chaabna, Sohaila Cheema, Amit Abraham, Hekmat Alrouh, Albert B. Lowenfels, Patrick Maisonneuve, Ravinder Mamtani

NYMC Faculty Publications

AIM: To assess the quality of and to critically synthesize the available data on hepatitis C infections in the Middle East and North Africa (MENA) region to map evidence gaps. METHODS: We conducted an overview of systematic reviews (SRs) following an a priori developed protocol (CRD42017076736). Our overview followed the preferred reporting items for systematic reviews and meta-analyses guidelines for reporting SRs and abstracts and did not receive any funding. Two independent reviewers systematically searched MEDLINE and conducted a multistage screening of the identified articles. Out of 5758 identified articles, 37 SRs of hepatitis C virus (HCV) infection in populations …


Risk Factors For Microvascular Complications Of Diabetes In A High-Risk Middle East Population, Sohaila Cheema, Patrick Maisonneuve, Mahmoud Zirie, Amin Jayyousi, Hekmat Alrouh, Albert B. Lowenfels, Ravinder Mamtani Jul 2018

Risk Factors For Microvascular Complications Of Diabetes In A High-Risk Middle East Population, Sohaila Cheema, Patrick Maisonneuve, Mahmoud Zirie, Amin Jayyousi, Hekmat Alrouh, Albert B. Lowenfels, Ravinder Mamtani

NYMC Faculty Publications

Aims: Much of the diabetes burden is caused by its complications. This cross-sectional study aimed to determine the prevalence and risk factors for diabetic microvascular complications (retinopathy, nephropathy, and neuropathy) in a high-risk population. Methods: We collected information via a structured questionnaire and directly from the patient's record on 1034 adult type 2 diabetic patients who were attending outpatient clinics in Qatar. Results: The mean age of the patients was 55 +/- 10 years, and the mean duration of diabetes was 12.4 +/- 8.9 years. Forty-five percent had one or more microvascular complications. Shared risk factors for multiplicity and for …